Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat (R) inhaler versus MDI

Creative Commons License

ZuWallack R., De Salvo M. C., Kaelin T., Bateman E. D., Park C. S., Abrahams R., ...Daha Fazla

RESPIRATORY MEDICINE, cilt.104, sa.8, ss.1179-1188, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 104 Sayı: 8
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1016/j.rmed.2010.01.017
  • Dergi Adı: RESPIRATORY MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1179-1188
  • Anahtar Kelimeler: COPD, Respimat (R) inhaler, Ipratropium bromide, Anticholinergic, Bronchodilator, OBSTRUCTIVE PULMONARY-DISEASE, SOFT MIST(TM) INHALER, COMBINATION, ALBUTEROL, AEROSOL, LUNG, FLUTICASONE, PROPIONATE, SALMETEROL, DEPOSITION
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Ankara Üniversitesi Adresli: Hayır

Özet

We compared the efficacy and safety of ipratropium bromide/albuterol delivered via Respimat (R) inhaler, a novel propellant-free inhaler, versus chlorofluorocarbon (CFC)-metered dose inhaler (MDI) and ipratropium Respimat (R) inhaler in patients with COPD.